Normally, the liver produces glucose to provide energy, but in people with type 2 diabetes, this process often becomes dysregulated, leading to higher blood sugar levels
Patients encountering online sources or private clinics offering this combination should exercise significant caution, as: Unregulated supply of investigational peptides carries serious safety risks Quality, purity, and dosing of unlicensed products cannot be guaranteed Use outside of a clinical trial setting is not supported by current evidence or regulatory frameworks For those seeking access to obesity treatments within a safe and monitored environment, NICE-approved pathways for existing licensed therapies remain the appropriate starting point
IGF-1 LR3 is not a drug, supplement, or food product, and is not for human consumption, veterinary use, or medical applications
If something feels off, your healthcare provider can help you explore whats going on and recommend next steps